Autolus Therapeutics PLC (NAS:AUTL)
$ 3.92 0.05 (1.29%) Market Cap: 1.04 Bil Enterprise Value: 335.67 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 55/100

Autolus Therapeutics plc - Special Call Transcript

Dec 09, 2019 / 01:30PM GMT
Release Date Price: $15.69 (+6.45%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Autolus ASH 2019 Data Investor Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Silvia Taylor, Vice President, Corporate Affairs and Communications. Please go ahead.

Silvia Taylor
Autolus Therapeutics plc - VP of Corporate Affairs & Communications

Thank you, Sarah. Good morning or good afternoon, everyone, and thank you for taking part in today's call to review the data highlights for Autolus' clinical data presented at the 2019 ASH Annual Meeting.

With me today is Dr. Christian Itin, our Chairman and Chief Executive Officer; and of course, Andrew Oakley, our CFO, is also with us.

Before we begin, I would like to remind you that during this call, we will be making forward-looking statements. All statements other than statements of historical facts contained in this presentation are forward-looking statements. Our actual results,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot